EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to afatinib

Oncogenic EGFR mutations are found in 10-35% of lung adenocarcinomas. Such mutations, which present most commonly as small in-frame deletions in exon 19 or point mutations in exon 21 (L858R), confer sensitivity to EGFR tyrosine kinase inhibitors (TKIs). In analyzing the tumor from a 33-year-old male...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Discov
Main Authors: Gallant, Jean-Nicolas, Sheehan, Jonathan H., Shaver, Timothy M., Bailey, Mark, Lipson, Doron, Chandramohan, Raghu, Brewer, Monica Red, York, Sally J., Kris, Mark G., Pietenpol, Jennifer A., Ladanyi, Marc, Miller, Vincent A., Ali, Siraj M., Meiler, Jens, Lovly, Christine M.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631701/
https://ncbi.nlm.nih.gov/pubmed/26286086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-15-0654
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares